Opus Genetics
$4.69
57
+$0.14+3.08% Wednesday 20:00
Statistics
Day High
4.96
Day Low
4.58
52W High
5.3
52W Low
0.65
Volume
599,962
Avg. Volume
940,445
Mkt Cap
323.44M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
8MayExpected
Expected EPS
-0.13026
Actual EPS
N/A
Financials
-523.4%Profit Margin
Unprofitable21.98MRevenue
-115.06MNet Income
Analyst Ratings
$10.57Average Price Target
The highest estimate is 15.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow IRD. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
EyePoint
EYPT
Mkt Cap1.06B
Bausch Health Companies
BHC
Mkt Cap2.62B
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Novartis
NVS
Mkt Cap237.61B
GSK
GSK
Mkt Cap94.51B
Abbvie
ABBV
Mkt Cap385.18B
Pfizer
PFE
Mkt Cap140.15B
Regenxbio
RGNX
Mkt Cap645.07M
About
Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. The company offers Phentolamine Ophthalmic Solution for reversal of mydriasis, as well as is in Phase III clinical trials for presbyopia and dim light or night vision disturbances. Its lead retinal product candidate is APX3330, a small-molecule inhibitor of reduction oxidation effector factor-1 protein that has completed Phase II clinical trial for the treatment of diabetic retinopathy. The company also develops APX2009 and APX2014 that are preclinical product candidates for retina indications. The company was formerly known as Ocuphire Pharma, Inc. Opus Genetics, Inc. was founded in 2018 and is headquartered in Farmington Hills, Michigan.
Show more...
CEO
Mr. George Magrath M.B.A., M.D., M.S.
Employees
18
Country
US
ISIN
US67577R1023
Listings
0 Comments
Share your thoughts
FAQ
What is Opus Genetics stock price today?▼
The current price of IRD is $4.69 USD — it has increased by +3.08% in the past 24 hours. Watch Opus Genetics stock price performance more closely on the chart.
What is Opus Genetics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Opus Genetics stocks are traded under the ticker IRD.
Is Opus Genetics stock price growing?▼
IRD stock has risen by +3.76% compared to the previous week, the month change is a +8.31% rise, over the last year Opus Genetics has showed a +402.9% increase.
What is Opus Genetics market cap?▼
Today Opus Genetics has the market capitalization of 323.44M
When is the next Opus Genetics earnings date?▼
Opus Genetics is going to release the next earnings report on May 08, 2026.
What were Opus Genetics earnings last quarter?▼
IRD earnings for the last quarter are -0.19 USD per share, whereas the estimation was -0.11 USD resulting in a -70% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Opus Genetics revenue for the last year?▼
Opus Genetics revenue for the last year amounts to 21.98M USD.
What is Opus Genetics net income for the last year?▼
IRD net income for the last year is -115.06M USD.
How many employees does Opus Genetics have?▼
As of April 02, 2026, the company has 18 employees.
In which sector is Opus Genetics located?▼
Opus Genetics operates in the Health Care sector.
When did Opus Genetics complete a stock split?▼
The last stock split for Opus Genetics was on November 06, 2020 with a ratio of 1:4.
Where is Opus Genetics headquartered?▼
Opus Genetics is headquartered in Durham, US.